home / stock / clrb / clrb news

CLRB News and Press, Cellectar Biosciences Inc. From 09/09/20

Stock Information
Company Name: Cellectar Biosciences Inc.
Stock Symbol: CLRB
Market: NASDAQ
Website: cellectar.com
Menu
CLRB CLRB Quote CLRB Short CLRB News CLRB Articles CLRB Message Board
Get CLRB Alerts

News, Short Squeeze, Breakout and More Instantly...
CLRB - Cellectar Reports Data on CLR 131 Phase 2 CLOVER-1 Study in Triple Class Refractory Multiple Myeloma Patients

FLORHAM PARK, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that a clinically meaningful 4...
CLRB - Cellectar Presents Poster at the AACR VIRTUAL MEETING: ADVANCES IN MALIGNANT LYMPHOMA

Poster highlights the Phase 2a study data in relapsed or refractory lymphoplasmacytic lymphoma (LPL)/Waldenstrom’s macroglobulinemia (WM) Interim results show 100% overall response rate and a 75% major response rate FLORHAM PARK, N.J., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Cell...

CLRB - GOLD, OSTK among premarket gainers

CureVac (NASDAQ: CVAC ) +47%  on making reasonable profit on COVID-19 vaccine. More news on: CureVac N.V., LMP Automotive Holdings, Inc., Microbot Medical Inc., Stocks on the move, , Read more ...

CLRB - 4 Penny Stocks To Buy Right Now According To Analysts

These Names Are On Analysts’ Lists Of Penny Stocks Right Now; Are They On Yours? Penny stocks aren’t just “short-term” movers or “lotto trades” as some might assume. If you’ve been a reader of our articles this year, you have come to learn tha...
CLRB - Cellectar Biosciences EPS beats by $0.04

Cellectar Biosciences (NASDAQ: CLRB ) : Q2 GAAP EPS of -$0.26 beats by $0.04 . More news on: Cellectar Biosciences, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CLRB - Cellectar Reports Second Quarter 2020 Financial Results and Provides a Corporate Update

FLORHAM PARK, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced financial results for the secon...

CLRB - Cellectar Announces Poster Presentation at the International Symposium on Pediatric Neuro-Oncology (ISPNO) Annual Meeting

FLORHAM PARK, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a poster presentation at the up...
CLRB - TAOP, KODK among premarket losers

Taoping (NASDAQ: TAOP ) -23% . More news on: Taoping Inc., Precipio, Inc., Socket Mobile, Inc., Stocks on the move, , Read more ...

CLRB - QCOM, UPS among premarket gainers

FSD Pharma (NASDAQ: HUGE ) +130% . on decision to surrender health Canada licenses for subsidiary FV Pharma. More news on: FSD Pharma Inc., Kandi Technologies Group, Inc., Edesa Biotech, Inc., Stocks on the move, , Read more ...

CLRB - Cellectar Announces Poster Presentation of Clinical Data at the American Association of Cancer Research (AACR) Annual Meeting

FLORHAM PARK, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced a poster presentation at the up...
Previous 10 Next 10